Clin Ophthalmol. 2013;7:2107-11. doi: 10.2147/OPTH.S53518. Epub 2013 Oct 30.

The association of human leukocyte antigen B27 with anterior uveitis in patients from the western region of Saudi Arabia: a retrospective study.

Clinical ophthalmology (Auckland, N.Z.)

Ahmed M Bawazeer, Heba Ismail Joharjy

PMID: 24204112 PMCID: PMC3817032 DOI: 10.2147/OPTH.S53518

Abstract

BACKGROUND: The association of human leukocyte antigen B27 (HLA-B27) with anterior uveitis is well known. The prevalence of HLA-B27 and its relation to anterior uveitis is related to race and geographic location. The association is strongest in Western countries and weakest in Eastern countries. Data regarding this association from Middle Eastern countries are limited. Thus, we undertook the study reported here to evaluate the association of HLA-B27 with anterior uveitis in patients in a tertiary center in the western region of the Saudi Arabia.

METHODS: The study involved a retrospective analysis of the records of patients with anterior uveitis, referred to the uveitis clinic in Magrabi Eye and Ear Hospital, Jeddah, Saudi Arabia, from 1999 to 2010. The cost-effectiveness of HLA-B27 testing was analyzed.

RESULTS: Among the 587 cases of uveitis, 335 (57.1%; mean age 37.56±12.82 years; 203 male and 132 female) cases were of anterior uveitis. All patients with anterior uveitis were investigated for HLA-B27 positivity. Idiopathic anterior uveitis was the most common (80%), followed by Fuchs heterochromic cyclitis (7.45%) and ankylosing spondylitis (3.8%). Only two patients were HLA-B27 positive. The cost-effectiveness of HLA-B27 testing was found to be 165,000 Saudi riyals (44,594 US dollars) per positive case.

CONCLUSION: HLA-B27-related uveitis appears to be very rare in our part of the world. Idiopathic uveitis is the most common type of anterior uveitis. The cost-effectiveness of HLA-B27 testing is low for patients with anterior uveitis in the western region of Saudi Arabia.

Keywords: Fuchs heterochromic cyclitis; HLA-B27; Saudi population; ankylosing spondylitis; cost-effectiveness; idiopathic anterior uveitis

References

1. Am J Ophthalmol. 2010 Oct;150(4):534-542.e2 - PubMed
2. Am J Med Sci. 1998 Oct;316(4):239-49 - PubMed
3. Ocul Immunol Inflamm. 2002 Dec;10(4):263-79 - PubMed
4. Saudi Med J. 2013 Apr;34(4):379-87 - PubMed
5. Int Ophthalmol. 1996-1997;20(4):223-8 - PubMed
6. Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88 - PubMed
7. Am J Ophthalmol. 1996 Jan;121(1):35-46 - PubMed
8. Am J Ophthalmol. 2005 Sep;140(3):509-16 - PubMed
9. J Ophthalmic Vis Res. 2011 Oct;6(4):233-40 - PubMed
10. J Clin Rheumatol. 2008 Feb;14(1):50-2 - PubMed
11. Curr Eye Res. 2005 Nov;30(11):943-8 - PubMed
12. Ocul Immunol Inflamm. 2009 Jan-Feb;17(1):11-6 - PubMed
13. Br J Ophthalmol. 2000 Jul;84(7):706-9 - PubMed
14. Graefes Arch Clin Exp Ophthalmol. 1997 Jan;235(1):5-9 - PubMed
15. Saudi Med J. 2011 Apr;32(4):364-8 - PubMed
16. Arch Ophthalmol. 1996 May;114(5):593-9 - PubMed
17. Scand J Rheumatol. 1995;24(4):225-7 - PubMed
18. Eur J Immunogenet. 1996 Feb;23(1):67-70 - PubMed
19. J R Soc Med. 2004 Jan;97(1):10-4 - PubMed
20. Am J Ophthalmol. 2008 Mar;145(3):472-9 - PubMed
21. Ocul Immunol Inflamm. 2010 Dec;18(6):424-31 - PubMed
22. Ophthalmic Epidemiol. 2002 Oct;9(4):239-49 - PubMed
23. Aust N Z J Ophthalmol. 1986 Aug;14(3):181-7 - PubMed
24. Curr Opin Rheumatol. 2001 Jul;13(4):285-90 - PubMed
25. N Z Med J. 2006 Mar 10;119(1230):U1886 - PubMed
26. Br J Ophthalmol. 2004 Apr;88(4):512-7 - PubMed
27. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):675-90 - PubMed

Publication Types

• Journal Article